Alexander Thompson

Active 1980–2025

164
Papers
33,108
Citations
80
h-index
154
i10-index

Citations

Citations per year for Alexander Thompson1976: 3 citations1982: 2 citations1983: 3 citations1984: 1 citations1985: 1 citations1986: 2 citations1988: 4 citations1989: 3 citations1990: 2 citations1991: 1 citations1992: 4 citations1994: 10 citations1995: 4 citations1996: 6 citations1997: 4 citations1998: 8 citations1999: 5 citations2000: 13 citations2001: 13 citations2002: 10 citations2003: 17 citations2004: 12 citations2005: 17 citations2006: 19 citations2007: 43 citations2008: 48 citations2009: 81 citations2010: 202 citations2011: 323 citations2012: 270 citations2013: 285 citations2014: 228 citations2015: 226 citations2016: 288 citations2017: 272 citations2018: 266 citations2019: 719 citations2020: 760 citations2021: 763 citations2022: 621 citations2023: 501 citations2024: 956 citations2025: 506 citations2026: 29 citations1977–1981: no citations, so these years are not shown1987: no citations, so this year is not shown1993: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,544 citing papers, 20% of this breakdownChina: 1,194 citing papers, 9.4% of this breakdownUnited Kingdom: 968 citing papers, 7.6% of this breakdownAustralia: 629 citing papers, 5% of this breakdownGermany: 620 citing papers, 4.9% of this breakdownItaly: 556 citing papers, 4.4% of this breakdownCanada: 490 citing papers, 3.9% of this breakdownFrance: 485 citing papers, 3.8% of this breakdownNetherlands: 382 citing papers, 3% of this breakdownSpain: 353 citing papers, 2.8% of this breakdownJapan: 331 citing papers, 2.6% of this breakdownSwitzerland: 266 citing papers, 2.1% of this breakdown
0%20%Other 30.5%

Fields

  • Medicine63%
  • Biochemistry, Genetics and Molecular Biology12.4%
  • Materials Science6.8%
  • Physics and Astronomy3.3%
  • Immunology and Microbiology2.8%
  • Engineering2.8%
  • Other8.9%

Topics

  • Hepatitis C virus research8.6%
  • Hepatitis B Virus Studies6.7%
  • Liver Disease Diagnosis and Treatment5.7%
  • Diabetes, Cardiovascular Risks, and Lipoproteins2.4%
  • Machine Learning in Materials Science2.3%
  • Lipoproteins and Cardiovascular Health1.7%
  • Other72.6%

Coauthors

All papers

Open in search
  1. Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rudolf Stauber, Matthias Pinter, Markus Peck‐Radosavljevic, Jochen Decaestecker, Pieter‐Jan Cuyle, Gontran Verset, Hans Van Vlierberghe, Sérgio de Azevedo, Livia Andrade, Ademar Cunha Júnior, Luiza Dib Batista Bugiato Faria, Cheng Tzu Yen, Leandro M. Colli, Jamil Asselah, Petr Kavan, Vladimir Marquez, Mayur Brahmania, Qiang Li, Bao-Cai Xing, Yabing Guo, Zhendong Chen, Haitao Zhao, Tao Peng, Liming Wang, Lu Wang, Hongming Liu, Feixiang Wu, Lun–Xiu Qin, Qichang Zheng, Jieer Ying, Haitao Li, Tianfu Wen, Shukui Qin, Xiaoyu Wen, Yunpeng Liu, Minshan Chen, Boqing Wang, Yuxian Bai, Yifu He, Hong Zhao, Dong Zhou, Chaoliu Dai, Gao‐Jun Teng, Shuzhong Cui, Yi Gao, Xizhi Zhang, Zheng Lu, Tao Yin, Youming Ding, Weidong Jia, Yongxiang Xia, Beicheng Sun, Qiang Xia, Yufeng Yuan, Hui‐Chuan Sun, Xuetao Shi, A. Guzmán, Luis Corrales, Zdeněk Král, Peter Priester, Eugen Kubala, Jean Frédéric Blanc, Marc Bourlière, Jean Marie Péron, Christophe Borg, Jean–Pierre Bronowicki, Nathalie Ganne, Thomas Decaens, Thomas Uguen, Alexandra Heurgué and 109 more - The Lancet 2023 cited by 488

  2. Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jennifer J. Knox, Janine M. Davies, Jamil Asselah, Mayur Brahmania, Habeeb Majeed, Luis J. Villanueva-Rivera, Patricio Yañez Weber, Marcelo Garrido, Gonzalo Pizarro, Nicolás Yáñez, Ruocai Xu, Shuangyan Ou, Zhenggang Ren, Hongming Pan, Zhiqiang Meng, Kangsheng Gu, Xi Chen, Tao Zhang, Chunyi Hao, Peiguo Cao, Yabing Guo, Shukui Qin, Juxiang Xiao, Weijia Fang, Xin Wang, Yuxian Bai, Xiaoming Chen, Dong Yan, Hong Zhao, Jieer Ying, Carlos Bonilla, Olga Urrego, Ángela R. Zambrano, Mauricio Lema, Juan Carlos Restrepo, Andrés F. Cardona, Sandra Franco Millan, Madiedo Oscar, Víctor Ramos, Philippe Merle, Samuel Lesourd, Julien Edeline, Jean–Pierre Bronowicki, Marc Bourlière, Stéphane Cattan, Mohamed Bouattour, Laurent Mineur, Hélène Regnault, Barbara Dauvois, Kornelius Schulze, Gunnar Folprecht, Andreas Geier, Oliver Waidmann, Fabian Finkelmeier, Marino Venerito, Marie‐Luise Berres, Thomas Berg, Christian M. Lange, Hartmut Schmidt, Dirk Waldschmidt, Michael Bitzer, Ray McDermott, Austin G. Duffy, Gianluca Masi, Vittorina Zagonel, Giuseppe Tonini, Fabio Piscaglia, Stefania Gori, Mimma Rizzo, Elisa Biscaldi and 109 more - The Lancet Oncology 2023 cited by 421

  3. The Open Quantum Materials Database (OQMD): assessing the accuracy of DFT formation energies

    Authors: , , , , , , , - npj Computational Materials 2015 cited by 2,351

  4. Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death

    Authors: , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2011 cited by 2,749

  5. Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , John Bate, Mark Danta, Jacob George, Alexander Hodge, Nickolas Kontorinis, S.A. Roberts, Santosh Sanagapalli, Richard Skoien, Alexander Thompson, Amany Zekry, Rudolf Stauber, Michael Trauner, Christophe Moreno, Hendrik Reynaert, Len Verbeke, Mário Reis Álvares‐da‐Silva, Edison Roberto Parise, Cláudia P. Oliveira, Roberta Chaves Araújo, Ana de Lourdes Candolo Martinelli, Meredith A. Borman, Natasha Chandok, Magdy Elkhashab, Hughie F. Fraser, Kelly Kaita, Mang Ma, Paul Marotta, Alnoor Ramji, Edward Tam, Eric M. Yoshida, Mark G. Swain, Giada Sebastiani, Denis Petrunia, Armand Abergel, Rodolphe Anty, Marc Bourlière, Jérôme Boursier, Christophe Bureau, Laurent Castéra, François Habersetzer, Christophe Hézode, V. de Lédinghen, Vincent Leroy, V. Loustaud‐Ratti, Philippe Mathurin, Stanislas Pol, Fabien Zoulim, Holger Hinrichsen, Patrick Ingiliz, Frank Lammert, Michael Manns, Jörn M. Schattenberg, Ingolf Schiefke, Christian Trautwein, Stefan Zeuzem, Aric J. Hui, K Li, Vincent Wai‐Sun Wong, Subrat Kumar Acharya, Abhijit Chowdhury, Ajay Duseja, Dharmesh Kapoor, Shrikant Mukewar, Shiv Kumar Sarin, Samir Shah, S. Shalimar, Ajit Sood, BV Tantry, Ziv Ben‐Ari, Helena Katchman and 540 more - Journal of Hepatology 2020 cited by 466

  6. A global scientific strategy to cure hepatitis B

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , William Mason, Gail Matthews, Dimitrios Paraskevis, Jörg Petersen, Barbara Rehermann, Eui‐Cheol Shin, Alexander Thompson, Florian van Bömmel, Fusheng Wang, Koichi Watashi, Hung‐Chih Yang, Zhenghong Yuan, Man‐Fung Yuen, Timothy M. Block, Veronica Miller, Ulrike Protzer, Christian Bréchot, Stephen Locarnini, Marion G. Peters, Raymond F. Schinazi, Fabien Zoulim - ˜The œLancet. Gastroenterology & hepatology 2019 cited by 495

  7. Interferometry and Synthesis in Radio Astronomy

    Authors: , , - Astronomy and astrophysics library 2001 cited by 2,411

  8. Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stefan Z. Wiktor, Ayman A. Abdo, Rakesh Aggarwal, Alessio Aghemo, Bandar Al‐Judaibi, Mamun Al Mahtab, Arshad Altaf, Zyaad Ameen, Tarik Asselah, Oidov Baatarkkhuu, Ella Barber, Eleanor Barnes, Pascale Boulet, Louise Burrows, Maia Butsashvili, Erica On-Ting Chan, Chelsea Chow, Ben Cowie, Chris Cunningham, Alexandre de Araújo, Graciela Diap, Gregory J. Dore, Joseph Doyle, Manal H. El‐Sayed, Emmanuel Fajardo, Ed Gane, Aneley Getahun, David Goldberg, Tiffany Got, Matthew Hickman, Andrew Hill, Sharon Hutchinson, Christopher R. Jones, Saleem Kamili, Amreen Khan, Alice Lee, Tin Yan Lee, Jioiji Malani, Tammy Meyers-Morris, Shevanthi Nayagam, Richard Njouom, Ponsiano Ocama, Alisa Pedrana, Rosanna Ŵ. Peeling, Amulya Reddy, Jilian A. Sacks, Shiv Kumar Sarin, Yusuke Shimakawa, Marcela Silva, Pavlo Skala, Simon D. Taylor‐Robinson, Alexander Thompson, Mark Thursz, Alfred Tonganibeia, Jack Wallace, James Ward, Fernando Herz Wolff, Peter Vickerman, Johnny Yau - ˜The œLancet. Gastroenterology & hepatology 2019 cited by 540

  9. APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Hepatology International 2021 cited by 171

  10. Combinatorial screening for new materials in unconstrained composition space with machine learning

    Authors: , , , , , , , , - Physical Review B 2014 cited by 753

  11. Epigenetic Silencing of RIPK3 in Hepatocytes Prevents MLKL-mediated Necroptosis From Contributing to Liver Pathologies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Justin A. Boddey, Marcel Doerflinger, Marc Pellegrini - Gastroenterology 2022 cited by 68

  12. Combination treatments including the small-interfering RNA JNJ-3989 induce rapid and sometimes prolonged viral responses in patients with CHB

    Authors: , , , , , , , , , , , , , , , , , , , , , - Journal of Hepatology 2022 cited by 104

  13. Lipid-Related Markers and Cardiovascular Disease Prediction

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , John Gallacher, F. Gerry R. Fowkes, Edoardo Casiglia, Albert Hofman, Veikko Salomaa, Elizabeth Barrett‐Connor, Robert Clarke, Eric J. Brunner, J. Wouter Jukema, Leon A. Simons, Manjinder S. Sandhu, Nicholas J. Wareham, Kay‐Tee Khaw, Jussi Kauhanen, Jukka T. Salonen, W.J. Howard, Børge G. Nordestgaard, Angela Wood, Simon G. Thompson, S. Matthijs Boekholdt, Naveed Sattar, Chris J. Packard, Vilmundur Guðnason, John Danesh - JAMA 2012 cited by 536

  14. Consolidated Health Economic Evaluation Reporting Standards for Interventions That Use Artificial Intelligence (CHEERS-AI)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David Vanness, Rossella Di Bidino, Susan Faulding, Federico Felizzi, Madeleine Haig, James Hawkins, Mikaël Hiligsmann, Annette Willemoes Holst-Kristensen, Julian Isla, Erik Koffijberg, Alexander Kostyuk, Noemi Krief, Dawn Lee, Karen Lee, Douglas Lundin, Katarzyna Markiewicz-Barreaux, Josephine Mauskopf, Karel Moons, Bertalan Németh, Guenka Petrova, Raoh-Fang (Jasmine) Pwu, Juan Carlos Rejon-Parrilla, Gabriel Rogers, Chris Sampson, Astrid Aaen Springborg, Lotte Steuten, Eric Sutherland, Jaakko Suutala, Daniel Theisen, Alexander Thompson, Lisette van Gemert-Pijnen, Thomas Walker, Ed Wilson - Value in Health 2024 cited by 57

  15. NGM282 for Treatment of Patients With Primary Biliary Cholangitis: A Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Trial

    Authors: , , , , , , , , , , - Hepatology Communications 2018 cited by 123

  16. First-in-human randomized study of RNAi therapeutic RG6346 for chronic hepatitis B virus infection

    Authors: , , , , , , , , , , , , , - Journal of Hepatology 2023 cited by 36

  17. Apolipoprotein(a) Isoforms and the Risk of Vascular Disease

    Authors: , , , , , , - Journal of the American College of Cardiology 2010 cited by 334

  18. The Global Impact of Hepatitis B Vaccination on Hepatocellular Carcinoma

    Authors: , , , - Vaccines 2022 cited by 90

  19. Standard gastroenterologist versus multidisciplinary treatment for functional gastrointestinal disorders (MANTRA): an open-label, single-centre, randomised controlled trial

    Authors: , , , , , , , , , , , , , - ˜The œLancet. Gastroenterology & hepatology 2020 cited by 124

  20. Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stuart C. Gordon, Keyur Patel, Nancy Reau, Alessandra Mangia, Mark Sulkowski - New England Journal of Medicine 2015 cited by 850

  21. A national programme to scale-up decentralised hepatitis C point-of-care testing and treatment in Australia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Philip A. Read, Alisa Pedrana, Alexander Thompson, Joss O’Loan - ˜The œLancet. Gastroenterology & hepatology 2023 cited by 37

  22. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

    Authors: , , , , , , , , , , , , - Nature 2009 cited by 3,528

  23. Lipoprotein-associated phospholipase A2 and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies

    Authors: , , , , , , , , , , , , , , - The Lancet 2010 cited by 597

  24. Long-Term Outcome of Multidisciplinary Versus Standard Gastroenterologist Care for Functional Gastrointestinal Disorders: A Randomized Trial

    Authors: , , , , , , , , , , , , , - Clinical Gastroenterology and Hepatology 2021 cited by 57